CNBC's own descriptionThe stakes are incredibly high for the U.S. to maintain its lead in data centers. It seems to be getting harder and harder in this election year.
News
Energy and royalties news
Income paid for the use of something owned: mineral and music royalties, pipeline partnerships and resource leases.
- Dividends1264
- Rates and cash64
- Bonds and credit109
- REITs and property22
- Preferred stock0
- Funds and ETFs28
- Energy and royalties14
- Private credit18
Sources last checked Aug 26, 2026 at 02:05 UTC · newest headline in this topic 2 days ago. Showing the 14 most recent of 14 stored under energy and royalties.
Sunday, Aug 23, 2026
Tuesday, Aug 18, 2026
Barron's's own descriptionAmylyx Pharmaceuticals says its GLP-1 receptor antagonist, avexitide, met both the primary and secondary endpoints in a late-stage clinical trial.
Thursday, Aug 06, 2026
The Wall Street Journal's own descriptionNovo Nordisk's Wegovy and Eli Lilly's Zepbound and Foundayo will be available at a cost of $50 a month.
Wednesday, Aug 05, 2026
MarketWatch's own descriptionThe Danish company developed the most lucrative new drug the world had ever seen. Then America's Eli Lilly outmaneuvered it and took control of the diet-drug market.
CNBC's own descriptionBank of America CEO Brian Moynihan said the company is spending more than $250 million annually to provide GLP-1 weight loss medications to its workforce. Moynihan told CNBC the expense has…
The Wall Street Journal's own descriptionEli Lilly reported higher net income and revenue in the recent quarter, fueled by continued surging demand for its GLP-1 weight-loss drugs.
The Wall Street Journal's own descriptionCVS Health said it will revamp its weight management program through a partnership with Eli Lilly as the company lifted its full-year outlook and reported a nearly threefold increase in its…
Monday, Aug 03, 2026
Reuters's own descriptionWilliams said on Monday it would buy Momentum Midstream for $5.5 billion and raise its full-year profit outlook, expanding its natural gas network in the Haynesville shale to serve…
Saturday, Aug 01, 2026
CNBC's own descriptionAs employers drop GLP-1 coverage, more Americans are being encouraged to use direct-to-consumer (DTC) weight-loss drug prescription programs. Major retailers and pharmacy chains, from CVS…
Saturday, Jul 25, 2026
CNBC's own descriptionShipping and logistics companies are tapping into the growing healthcare market as cold chain and temperature-controlled facilities become more crucial. Those companies are investing…
Thursday, Jul 23, 2026
CNBC's own descriptionThe increasing rate of patients using GLP-1 medications is now boosting growth in Galderma's aesthetics portfolio, CEO Flemming Ørnskov told CNBC on Thursday. About 10% of U.S. adults now…
Tuesday, Jul 21, 2026
MarketWatch's own descriptionThe drugmaker says Lilly isn't including the most up-to-date clinical information about its drugs
The Wall Street Journal's own descriptionThe maker of Ozempic and Wegovy says its competitor is misleading consumers by citing outdated weight-loss data in advertisements.
CNBC's own descriptionNovo Nordisk filed a lawsuit against Eli Lilly, alleging that its advertising campaigns for its blockbuster obesity and diabetes drugs are designed to mislead consumers about their superior…
The mechanics behind these headlines
A news feed tells you what happened. These pages explain how the instrument works, what it costs, how it is taxed and what can go wrong.
The current numbers for this corner of the market live in Royalties, which is built from the database rather than from headlines. The Learn pages below cover the terms a story in this topic is likely to use without defining them.
- Oil and gas royalty interests
- Mineral rights
- Master limited partnerships
- Royalty trusts
- Music royalties
- Royalties — the current data for this topic
- All income news — every topic, newest first
Only 72 named publishers can appear in this feed — wire services, mainstream business press, and specialist market titles. Press-release distribution wires, law-firm class-action solicitations, stock-promotion copy and syndication portals are blocked outright, including when they arrive under an allowed byline. Anything matching none of the income topics below is dropped rather than filed under a catch-all. The full allowlist is published on the news index.